메뉴 건너뛰기




Volumn 47, Issue SUPPL. 1, 2008, Pages 49-51

Tophi as first clinical sign of gout

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; COLCHICINE; FLUCLOXACILLIN; NAPROXEN;

EID: 56049116232     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03961.x     Document Type: Conference Paper
Times cited : (25)

References (9)
  • 1
  • 2
    • 33750971448 scopus 로고    scopus 로고
    • Metabolic diseases: Gout
    • Falasca GF. Metabolic diseases: Gout. Clin Dermatol 2006; 24: 498-508.
    • (2006) Clin Dermatol , vol.24 , pp. 498-508
    • Falasca, G.F.1
  • 4
    • 33646703978 scopus 로고    scopus 로고
    • New insights into gout epidemiology
    • Mikuls TR, Saag KG. New insights into gout epidemiology. Curr Opin Rheumatol 2006; 18: 199-203.
    • (2006) Curr Opin Rheumatol , vol.18 , pp. 199-203
    • Mikuls, T.R.1    Saag, K.G.2
  • 5
    • 13344281990 scopus 로고    scopus 로고
    • Gout epidemiology: Results from the UK General Practice Research Database, 1990-1999
    • Mikuls TR, Farrar JT, Bilker WB, et. al. Gout epidemiology: Results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005; 64: 267-272.
    • (2005) Ann Rheum Dis , vol.64 , pp. 267-272
    • Mikuls, T.R.1    Farrar, J.T.2    Bilker, W.B.3
  • 6
    • 23244458812 scopus 로고    scopus 로고
    • Gouty panniculitis: A case report and review of the literature
    • Snider AA, Barsky S. Gouty panniculitis: A case report and review of the literature. Cutis 2005; 76: 54-56.
    • (2005) Cutis , vol.76 , pp. 54-56
    • Snider, A.A.1    Barsky, S.2
  • 7
    • 33750374233 scopus 로고    scopus 로고
    • EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
    • Zhang W, Doherty M, Pascual E, et al. EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1301-1311.
    • (2006) Ann Rheum Dis , vol.65 , pp. 1301-1311
    • Zhang, W.1    Doherty, M.2    Pascual, E.3
  • 8
    • 33748608331 scopus 로고    scopus 로고
    • EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
    • Zhang W, Doherty M, Bardin T, et al. EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1312-1324.
    • (2006) Ann Rheum Dis , vol.65 , pp. 1312-1324
    • Zhang, W.1    Doherty, M.2    Bardin, T.3
  • 9
    • 35448936489 scopus 로고    scopus 로고
    • British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group (SGAWG). British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout
    • Jordan KM, Cameron JS, Snaith M, et al. British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group (SGAWG). British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) 2007; 46: 1372-1374.
    • (2007) Rheumatology (Oxford) , vol.46 , pp. 1372-1374
    • Jordan, K.M.1    Cameron, J.S.2    Snaith, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.